Active glycation in neurofibrillary pathology of Alzheimer disease: Nε-(Carboxymethyl) lysine and hexitol-lysine

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Free Radical Biology and Medicine

• Publication date

  2001-07-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0891-5849(01)00570-6
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Chemistry and biochemistry of oxidative stress in neurodegenerative disease.

  2001cited by this paper
• In Situ Oxidative Catalysis by Neurofibrillary Tangles and Senile Plaques in Alzheimer’s Disease

  2000cited by this paper
• Detection of an Amadori product, 1-hexitol-lysine, in the anterior horn of the amyotrophic lateral sclerosis and spinobulbar muscular atrophy spinal cord: evidence for early involvement of glycation in motoneuron diseases

  2000cited by this paper
• Redox metals and neurodegenerative disease.

  1999cited by this paper
• 2‐Isopropylidenehydrazono‐4‐oxo‐thiazolidin‐5‐ylacetanilide (OPB‐9195) treatment inhibits the development of intimal thickening after balloon injury of rat carotid artery: role of glycoxidation and lipoxidation reactions in vascular tissue damage

  1999cited by this paper
• Protein aging by carboxymethylation of lysines generates sites for divalent metal and redox active copper binding: relevance to diseases of glycoxidative stress.

  1999cited by this paper
• Conversion of Amadori product of Maillard reaction to N ϵ‐(carboxymethyl)lysine in alkaline condition

  1998cited by this paper
• Glycoxidation in aortic collagen from STZ-induced diabetic rats and its relevance to vascular damage.

  1998cited by this paper
• Extracellular matrix in human diabetic nephropathy: reduced expression of heparan sulphate in skin basement membrane

  1998cited by this paper
• Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging.

  1997cited by this paper
• Iron accumulation in Alzheimer disease is a source of redox-generated free radicals.

  1997cited by this paper
• Immunohistochemical localization of advanced glycation end products, pentosidine, and carboxymethyllysine in lipofuscin pigments of Alzheimer's disease and aged neurons.

  1997cited by this paper
• 4‐Hydroxynonenal‐Derived Advanced Lipid Peroxidation End Products Are Increased in Alzheimer's Disease

  1997cited by this paper
• E-4-hydroxy-2-nonenal is cytotoxic and cross-links cytoskeletal proteins in P19 neuroglial cultures.

  1996cited by this paper
• Quantitative solubilization and analysis of insoluble paired helical filaments from Alzheimer disease.

  1996cited by this paper
• The Advanced Glycation End Product, N-(Carboxymethyl)lysine, Is a Product of both Lipid Peroxidation and Glycoxidation Reactions (*)

  1996cited by this paper
• Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease.

  1996cited by this paper
• N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction.

  1996cited by this paper
• Immunohistochemical study of advanced glycation end products in aging and Alzheimer's disease brain.

  1996cited by this paper
• Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody.

  1995cited by this paper
• N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins.

  1995cited by this paper
• Early AGEing and Alzheimer's

  1995cited by this paper
• Immunological detection of glycated proteins in normal and streptozotocin-induced diabetic rats using anti hexitol-lysine IgG.

  1995cited by this paper
• Are advanced glycation end-products associated with amyloidosis in Alzheimer’s disease?

  1995cited by this paper
• Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress.

  1994cited by this paper
• Advanced glycation end products contribute to amyloidosis in Alzheimer disease.

  1994cited by this paper
• Advanced Maillard reaction end products are associated with Alzheimer disease pathology

  1994cited by this paper
• Analysis of microtubule-associated protein tau glycation in paired helical filaments.

  1994cited by this paper
• Age-dependent accumulation of N epsilon-(carboxymethyl)lysine and N epsilon-(carboxymethyl)hydroxylysine in human skin collagen.

  1991cited by this paper
• Neuropil threads of Alzheimer's disease show a marked alteration of the normal cytoskeleton

  1991cited by this paper
• Methods of Enzymology.

  1956cited by this paper

• Oral bacterium contributes to periodontal inflammation by forming advanced glycation end products

  2025cites this paper
• The Use of Advanced Glycation End-Product Measurements to Predict Post-Operative Complications After Cardiac Surgery

  2025cites this paper
• Dietary galactose exacerbates autoimmune neuroinflammation via advanced glycation end product-mediated neurodegeneration

  2024cites this paper
• The alteration and role of glycoconjugates in Alzheimer’s disease

  2024cites this paper
• The roles of dietary polyphenols at crosstalk between type 2 diabetes and Alzheimer's disease in ameliorating oxidative stress and mitochondrial dysfunction via PI3K/Akt signaling pathways.

  2024cites this paper
• HIF-1α serves as a co-linker between AD and T2DM.

  2024cites this paper
• Nutraceuticals as therapeutic interventions in Alzheimer's disease

  2023cites this paper
• Evaluation of the relationship among gene expressions and enzyme activities with antioxidant role and presenilin 1 expression in Alzheimer's disease

  2023cites this paper
• Advanced Glycation End Products in Health and Disease

  2022cites this paper
• Electric fields regulate cellular elasticity through intracellular Ca2+ concentrations

  2021cites this paper
• Long-term incubation of myoglobin with glyoxal induces amyloid like aggregation of the heme protein: Implications of advanced glycation end products in protein conformational disorders

  2021cites this paper
• Role of Hypoxia Inducible Factor-1α in Alzheimer’s Disease

  2021cites this paper
• Advanced Glycation End Products in Chinese Medicine Mediated Aging Diseases: A Review.

  2020cites this paper
• Utility of Reactive Species Generation in Plasma Medicine for Neuronal Development

  2020cites this paper
• Citrus spp. essential oils improve behavioral pattern, repressed cholinesterases and monoamine oxidase activities, and production of reactive species in fruit fly (Drosophila melanogaster) model of Alzheimer's Disease.

  2020cites this paper
• Nutraceuticals in Neurological Disorders

  2020cites this paper
• Application of atomic force microscope in diagnosis of single cancer cells.

  2020cites this paper
• The Significance of Tau Aggregates in the Human Brain

  2020cites this paper
• Interferometric Investigation of Cell Stiffness and Morphology on Oxidative Stress- Induced Human Umbilical Vein Endothelial Cells (HUVEC)

  2020cites this paper
• The Role of Glycation on the Aggregation Properties of IAPP

  2020cites this paper
• Methylglyoxal and Glyoxal as Potential Peripheral Markers for MCI Diagnosis and Their Effects on the Expression of Neurotrophic, Inflammatory and Neurodegenerative Factors in Neurons and in Neuronal Derived-Extracellular Vesicles

  2019cites this paper
• Use of High-Resolution Pressure Nephelometry To Measure Gas Vesicle Collapse as a Means of Determining Growth and Turgor Changes in Planktonic Cyanobacteria

  2019cites this paper
• High-resolution pressure nephelometer development: utilizing an updated method to measure gas vesicle collapse as a robust and expanded means of determining growth and turgor changes in planktonic cyanobacteria

  2019cites this paper
• An activatable near-infrared fluorescent probe for methylglyoxal imaging in Alzheimer's disease mice.

  2019cites this paper
• Site-specific glycations of Aβ1–42 affect fibril formation and are neurotoxic

  2019cites this paper
• Site-specific glycation of Aβ1–42 affects fibril formation and is neurotoxic

  2019cites this paper
• Circulating and Extracellular Vesicles Levels of N-(1-Carboxymethyl)-L-Lysine (CML) Differentiate Early to Moderate Alzheimer’s Disease

  2019cites this paper
• The Effectiveness of Vitamin E Treatment in Alzheimer’s Disease

  2019cites this paper
• Benfotiamine treatment activates the Nrf2/ARE pathway and is neuroprotective in a transgenic mouse model of tauopathy

  2018cites this paper
• The Inhibition of Advanced Glycation End Products by Carnosine and Other Natural Dipeptides to Reduce Diabetic and Age-Related Complications.

  2018cites this paper
• Hawaii Dementia Prevention Trial: A Randomized Trial Evaluating a Multifaceted Nutritional Intervention to Slow Cognitive Decline in Mild Cognitive Impairment Patients

  2018cites this paper
• A Proteomic Approach to Uncover Neuroprotective Mechanisms of Oleocanthal against Oxidative Stress

  2018cites this paper
• iProtGly‐SS: Identifying protein glycation sites using sequence and structure based features

  2018cites this paper
• Tau Biology, Tauopathy, Traumatic Brain Injury, and Diagnostic Challenges

  2018cites this paper
• Evidence-Based Complementary and Alternative Medicine Natural Products as an Emerging Therapeutic Alternative in the Treatment of Neurological Disorders

  2018cites this paper
• AFM Indentation Analysis of Cells to Study Cell Mechanics and Pericellular Coat.

  2018cites this paper
• Anticonvulsant and Neuroprotective Activities of Phragmanthera austroarabica Extract in Pentylenetetrazole-Kindled Mice

  2017cites this paper
• Diabetic Microvascular Disease: An Endocrine Society Scientific Statement

  2017cites this paper
• Glyco-redox, a link between oxidative stress and changes of glycans: Lessons from research on glutathione, reactive oxygen and nitrogen species to glycobiology.

  2016cites this paper
• [Oxidative stress and Alzheimer's disease].

  2016cites this paper
• Neuroprotective Effect of Melatonin in the Hippocampus of Rat ’ s Brain in Normal Aging Model

  2016cites this paper
• Human amylin proteotoxicity impairs protein biosynthesis, and alters major cellular signaling pathways in the heart, brain and liver of humanized diabetic rat model in vivo

  2016cites this paper
• Glycation vs. glycosylation: a tale of two different chemistries and biology in Alzheimer’s disease

  2016cites this paper
• Tackling Alzheimer’s Disease by Targeting Oxidative Stress and Mitochondria

  2016cites this paper
• AFM study shows prominent physical changes in elasticity and pericellular layer in human acute leukemic cells due to inadequate cell–cell communication

  2016cites this paper
• Protein carbamylation is a hallmark of aging

  2015cites this paper
• Inhibitory effects and actions of pentacyclic triterpenes upon glycation

  2015cites this paper
• Recovery of Aging-Related Size Increase of Skin Epithelial Cells: In vivo Mouse and In vitro Human Study

  2015cites this paper
• ОЦЕНКА УПРУГОЭЛАСТИЧЕСКИХ СВОЙСТВ НЕЙТРОФИЛОВ КРОВИ МЕТОДОМ АТОМНО-СИЛОВОЙ МИКРОСКОПИИ У ПАЦИЕНТОВ С ХРОНИЧЕСКОЙ ОБСТРУКТИВНОЙ БОЛЕЗНЬЮ ЛЕГКИХ

  2015cites this paper
• Buccal Cytome Biomarkers and Their Association with Plasma Folate, Vitamin B12 and Homocysteine in Alzheimer's Disease

  2015cites this paper
• Circulating Oxidative Damage and Antioxidant Defense System Biomarkers in Early Stage Alzheimer’s Disease

  2015cites this paper
• Genetic Factors in Environmentally Induced Disease

  2015cites this paper
• High-resolution high-speed dynamic mechanical spectroscopy of cells and other soft materials with the help of atomic force microscopy

  2015cites this paper
• Emerging role of advanced glycation-end products (AGEs) in the pathobiology of eye diseases.

  2014cites this paper
• Improved Neuroprotective Effects by Combining Bacopa monnieri and Rosmarinus officinalis Supercritical CO2 Extracts

  2014cites this paper
• The role of advanced glycation end products in various types of neurodegenerative disease: a therapeutic approach

  2014cites this paper
• Role of Methylglyoxal in Alzheimer's Disease

  2014cites this paper
• Natural Compounds (Small Molecules) as Potential and Real Drugs of Alzheimer's Disease

  2014cites this paper
• If cell mechanics can be described by elastic modulus: study of different models and probes used in indentation experiments.

  2014cites this paper
• Alzheimer's Disease: Pathology and Pathogenesis

  2014cites this paper
• Neuroprotective effects of inhaled lavender oil on scopolamine-induced dementia via anti-oxidative activities in rats.

  2013cites this paper
• Effects of Edaravone on Scopolamine Induced-dementia in Experimental Rats

  2013cites this paper
• Pioglitazone alleviates the mitochondrial apoptotic pathway and mito‐oxidative damage in the d‐galactose‐induced mouse model

  2013cites this paper
• Microglia demostrate age-dependent performance and interaction with beta-amyloid peptide

  2013cites this paper
• Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.

  2013influential citation
• Nutrients and Food Constituents in Cognitive Decline and Neurodegenerative Disease

  2013cites this paper
• Neurofilaments are the major neuronal target of hydroxynonenal-mediated protein cross-links

  2013cites this paper
• Method for quantitative measurements of the elastic modulus of biological cells in AFM indentation experiments.

  2013cites this paper
• Atomic force microscopy of 3T3 and SW-13 cell lines: an investigation of cell elasticity changes due to fixation.

  2013cites this paper
• Hyperglycemia and the brain

  2013cites this paper
• Anti-glycative potential of triterpenes: A mini-review

  2012cites this paper
• Understanding Secondary Injury

  2012cites this paper
• Amyloid-β Metabolite Sensing: Biochemical Linking of Glycation Modification and Misfolding

  2012cites this paper
• Oxidative Damage to RNA in Aging and Neurodegenerative Disorders

  2012cites this paper
• Hydroxynonenal-generated crosslinking fluorophore accumulation in Alzheimer disease reveals a dichotomy of protein turnover.

  2012cites this paper
• Mitochondrial importance in Alzheimer's, Huntington's and Parkinson's diseases.

  2012cites this paper
• Insulin signaling, glucose metabolism and mitochondria: major players in Alzheimer's disease and diabetes interrelation.

  2012cites this paper
• Nanoparticle delivery of transition-metal chelators to the brain: Oxidative stress will never see it coming!

  2012cites this paper
• Crosstalk between advanced glycation and endoplasmic reticulum stress: emerging therapeutic targeting for metabolic diseases.

  2012cites this paper
• Is antioxidant therapy effective to treat alzheimer's disease?

  2011cites this paper
• AGE-RAGE in Multiple Sclerosis Brain

  2011cites this paper
• Lipid peroxidation in Alzheimer’s Disease: emphasis on metal‐mediated neurotoxicity

  2011cites this paper
• Aluminum, copper, iron and zinc differentially alter amyloid-Aβ(1-42) aggregation and toxicity.

  2011cites this paper
• The role of environmental exposures in neurodegeneration and neurodegenerative diseases.

  2011cites this paper
• Age-Related Macular Degeneration (AMD): Alzheimer's Disease in the Eye?

  2011cites this paper
• Advanced glycation end products, diabetes, and the brain

  2011cites this paper
• Frontiers in Alzheimer’s disease therapeutics

  2011cites this paper
• Oxidative Stress in Alzheimer’s Disease: Pathogenesis, Biomarkers and Therapy

  2011cites this paper
• Antioxidant Activity of Wine Polyphenols for Alzheimer Prevention

  2011cites this paper
• Oxidative Stress in Alzheimer’s Disease: A Critical Appraisal of the Causes and the Consequences

  2011cites this paper
• Oxidative Stress and Alzheimer Disease: Mechanisms and Therapeutic Opportunities

  2011cites this paper
• Insulin-resistant brain state: the culprit in sporadic Alzheimer's disease?

  2011cites this paper
• Hydrogen-rich saline improves memory function in a rat model of amyloid-beta-induced Alzheimer's disease by reduction of oxidative stress.

  2010cites this paper
• Advanced glycation end products as biomarkers and gerontotoxins - A basis to explore methylglyoxal-lowering agents for Alzheimer's disease?

  2010cites this paper
• N(ɛ)-(carboxymethyl)lysine linkage to α-synuclein and involvement of advanced glycation end products in α-synuclein deposits in an MPTP-intoxicated mouse model.

  2010cites this paper
• Does accumulation of advanced glycation end products contribute to the aging phenotype?

  2010cites this paper
• Novel therapeutics for Alzheimer's disease: an update.

  2010cites this paper
• Effect of the overexpression of mutant ubiquitin (K48R) on the cellular response induced by 4-hydroxy-2,3-trans-nonenal, an end-product of lipid peroxidation.

  2010cites this paper
• Neuroprotective effects of anthocyanins on neuronal death induced by inhibition of BCL-2 and mitochondrial oxidative stress

  2010cites this paper
• Increased Iron and Free Radical Generation in Preclinical Alzheimer Disease and Mild Cognitive Impairment

  2010cites this paper